Ambu A/S header image

Ambu A/S

AMBU B

Equity

ISIN DK0060946788 / Valor 39639588

Nasdaq Copenhagen Equities (2026-04-24)
DKK 65.05-1.66%

Ambu A/S
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Ambu A/S is a Danish multinational medical technology company specializing in the development, manufacturing, and distribution of single-use endoscopy solutions, as well as products for anesthesia and patient monitoring. The company is recognized as a market leader in single-use endoscopy, offering a comprehensive portfolio that covers pulmonology, urology, ear-nose-throat (ENT), and gastroenterology (GI). Ambu's endoscopes are designed to operate on a unified platform, providing healthcare professionals with an interconnected system that enhances workflow efficiency and patient care. In addition to its endoscopy solutions, Ambu maintains a strong presence in the fields of anesthesia and patient monitoring, with a legacy that includes the invention of the first self-inflating resuscitator, known as the "Ambu bag," in 1956. The company operates globally, with production facilities in the USA, China, Malaysia, and Mexico, and serves over 100 million patients worldwide. Ambu's commitment to innovation and quality continues to drive its mission to support healthcare professionals in saving lives and improving patient outcomes.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-44.4%1Y
-37.9%3Y
-81.1%5Y

Performance

38.2%1Y
39.5%3Y
48.5%5Y

Volatility

Market cap

2365 M

Market cap (USD)

Daily traded volume (Shares)

798,751

Daily traded volume (Shares)

1 day high/low

107.55 / 106.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.10%USD 31.57
Addus HomeCare Corp
Addus HomeCare Corp Addus HomeCare Corp Valor: 10385048
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.32%USD 95.71
Sareum Holdings PLC
Sareum Holdings PLC Sareum Holdings PLC Valor: 116566624
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.38%GBP 0.20
Summit Therapeutics Inc
Summit Therapeutics Inc Summit Therapeutics Inc Valor: 56903013
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.85%USD 22.08
Acadia Healthcare Co Inc
Acadia Healthcare Co Inc Acadia Healthcare Co Inc Valor: 14151414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%USD 27.38
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.99%USD 22.42
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.10%CHF 84.52
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.74%USD 24.10
Viatris Inc
Viatris Inc Viatris Inc Valor: 58198423
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.08%USD 14.59
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%CHF 281.40